Balchem (BCPC) director Daniel Knutson granted 870 restricted stock shares

Rhea-AI Filing Summary

Balchem Corporation director Daniel E. Knutson reported an equity award of company stock. On 02/11/2026, he acquired 870 shares of Balchem common stock as a grant or award at a stated price of $0 per share, increasing his directly held stake to 6,899 shares.

The award is in the form of restricted stock that vests one year after the grant date. Until vesting, the shares are subject to transfer restrictions under a Restricted Stock Grant Agreement between Balchem and Knutson, meaning he must satisfy those conditions before the shares fully vest.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Knutson Daniel E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	870	$0.00	--

Holdings After Transaction: Common Stock — 6,899 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Knutson Daniel E

(Last) (First) (Middle)

C/O BALCHEM CORPORATION

5 PARAGON DRIVE

(Street)

MONTVALE NJ 07645

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BALCHEM CORP [ BCPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/11/2026		A		870(1)	A	$0	6,899	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Ownership of restricted stock vests in Reporting Person 1 year following the grant date, subject to restrictions of transfer in accordance with the provisions of the Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

	/s/ Travis Larsen, Attorney in Fact for Daniel E Knutson	02/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Balchem (BCPC) director Daniel E. Knutson report?

Daniel E. Knutson reported receiving 870 shares of Balchem common stock as a grant or award. The Form 4 shows this as an acquisition of non-derivative securities, increasing his directly owned holdings to 6,899 shares after the reported transaction.

When did the reported Balchem (BCPC) insider stock grant occur?

The stock grant to Balchem director Daniel E. Knutson occurred on 02/11/2026. This transaction date is disclosed in the Form 4 and reflects when the 870 restricted shares of common stock were awarded and recorded as acquired by the reporting person.

How many Balchem (BCPC) shares does Daniel E. Knutson own after this Form 4?

After the reported grant, Daniel E. Knutson beneficially owns 6,899 shares of Balchem common stock directly. The Form 4 lists this figure as the amount of non-derivative securities beneficially owned following the 870-share restricted stock acquisition.

What are the vesting terms of Daniel E. Knutson’s Balchem (BCPC) restricted stock?

The restricted stock vests one year after the grant date. Until vesting, the shares are subject to transfer restrictions under a Restricted Stock Grant Agreement between Balchem and Knutson, meaning he must meet those conditions before gaining full unrestricted ownership.

Was the Balchem (BCPC) insider transaction an open-market buy or a stock award?

The transaction was a stock award, not an open-market purchase. The Form 4 uses transaction code “A” for a grant, award, or other acquisition, and lists a price of $0 per share for the 870 Balchem common shares received.

Is Daniel E. Knutson a director or officer of Balchem (BCPC) in this filing?

In this filing, Daniel E. Knutson is identified as a director of Balchem Corporation. The Form 4 indicates his relationship to the issuer by checking the director status box, with no officer title or 10% owner status marked.